Kevin Raney
Concepts (318)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Helicases | 49 | 2022 | 132 | 14.290 |
Why?
| DNA | 38 | 2023 | 581 | 7.450 |
Why?
| DNA, Single-Stranded | 29 | 2023 | 73 | 6.300 |
Why?
| G-Quadruplexes | 13 | 2023 | 81 | 5.980 |
Why?
| Saccharomyces cerevisiae Proteins | 13 | 2023 | 170 | 5.070 |
Why?
| Viral Proteins | 20 | 2021 | 158 | 4.650 |
Why?
| RNA Helicases | 12 | 2022 | 31 | 4.110 |
Why?
| Viral Nonstructural Proteins | 16 | 2022 | 61 | 3.850 |
Why?
| Hepacivirus | 14 | 2022 | 127 | 3.370 |
Why?
| Saccharomyces cerevisiae | 13 | 2023 | 218 | 2.380 |
Why?
| Adenosine Triphosphate | 15 | 2023 | 242 | 2.330 |
Why?
| DNA-Binding Proteins | 11 | 2017 | 462 | 2.240 |
Why?
| Nucleic Acid Conformation | 20 | 2020 | 99 | 2.200 |
Why?
| Bacteriophage T4 | 12 | 2021 | 23 | 2.190 |
Why?
| RNA | 9 | 2022 | 202 | 2.050 |
Why?
| DNA, Fungal | 5 | 2017 | 42 | 1.800 |
Why?
| DEAD-box RNA Helicases | 4 | 2021 | 35 | 1.780 |
Why?
| Models, Molecular | 10 | 2017 | 423 | 1.610 |
Why?
| Kinetics | 22 | 2019 | 692 | 1.470 |
Why?
| DNA Replication | 7 | 2020 | 152 | 1.440 |
Why?
| Oligonucleotides | 11 | 2012 | 76 | 1.260 |
Why?
| Nucleic Acids | 3 | 2023 | 13 | 1.240 |
Why?
| DNA, Viral | 5 | 2015 | 143 | 1.200 |
Why?
| Enzyme Inhibitors | 2 | 2021 | 446 | 1.190 |
Why?
| Protein Binding | 19 | 2019 | 736 | 1.180 |
Why?
| Adenosine Triphosphatases | 11 | 2016 | 90 | 1.090 |
Why?
| Transcription Factors | 4 | 2017 | 622 | 1.060 |
Why?
| Escherichia coli Proteins | 4 | 2017 | 100 | 0.990 |
Why?
| Substrate Specificity | 12 | 2021 | 209 | 0.930 |
Why?
| Peptide Nucleic Acids | 8 | 2006 | 17 | 0.930 |
Why?
| Hepatitis C | 2 | 2022 | 94 | 0.930 |
Why?
| Protein Structure, Tertiary | 9 | 2014 | 289 | 0.860 |
Why?
| Base Pairing | 6 | 2019 | 28 | 0.860 |
Why?
| Virus Replication | 3 | 2021 | 143 | 0.850 |
Why?
| Enzyme Assays | 1 | 2021 | 12 | 0.780 |
Why?
| Base Sequence | 15 | 2019 | 719 | 0.760 |
Why?
| Cytoplasm | 2 | 2021 | 109 | 0.750 |
Why?
| Streptavidin | 5 | 2021 | 14 | 0.740 |
Why?
| Catalysis | 10 | 2021 | 98 | 0.710 |
Why?
| Mitochondrial Proteins | 2 | 2017 | 121 | 0.710 |
Why?
| Protein Interaction Mapping | 3 | 2016 | 44 | 0.690 |
Why?
| Nucleic Acid Heteroduplexes | 3 | 2012 | 5 | 0.680 |
Why?
| Thiobarbiturates | 1 | 2018 | 23 | 0.680 |
Why?
| RecQ Helicases | 2 | 2015 | 19 | 0.650 |
Why?
| Liver Neoplasms | 1 | 2022 | 352 | 0.650 |
Why?
| DNA Damage | 2 | 2021 | 357 | 0.650 |
Why?
| Genomic Instability | 3 | 2017 | 95 | 0.640 |
Why?
| Nucleic Acid Denaturation | 6 | 2015 | 14 | 0.630 |
Why?
| DNA, Mitochondrial | 2 | 2020 | 186 | 0.580 |
Why?
| Sequence Homology, Amino Acid | 3 | 2017 | 180 | 0.580 |
Why?
| Cytoplasmic Granules | 1 | 2016 | 24 | 0.570 |
Why?
| Protein Interaction Maps | 1 | 2016 | 25 | 0.560 |
Why?
| Indoles | 1 | 2018 | 289 | 0.550 |
Why?
| DNA Repair | 4 | 2020 | 203 | 0.550 |
Why?
| Molecular Motor Proteins | 3 | 2011 | 9 | 0.550 |
Why?
| RNA, Fungal | 1 | 2016 | 30 | 0.540 |
Why?
| Biocatalysis | 2 | 2014 | 20 | 0.520 |
Why?
| DNA, Complementary | 1 | 2014 | 145 | 0.500 |
Why?
| Escherichia coli | 5 | 2012 | 250 | 0.500 |
Why?
| Amino Acid Sequence | 9 | 2017 | 767 | 0.500 |
Why?
| Protein Biosynthesis | 1 | 2016 | 273 | 0.480 |
Why?
| Bacterial Proteins | 4 | 2021 | 456 | 0.460 |
Why?
| Crystallography, X-Ray | 6 | 2019 | 178 | 0.460 |
Why?
| Recombinant Proteins | 8 | 2021 | 570 | 0.440 |
Why?
| Repressor Proteins | 2 | 2021 | 165 | 0.440 |
Why?
| Biotin | 4 | 2001 | 45 | 0.430 |
Why?
| RNA, Messenger | 1 | 2016 | 1203 | 0.430 |
Why?
| Telomere | 3 | 2023 | 36 | 0.420 |
Why?
| Aflatoxin B1 | 8 | 1994 | 15 | 0.410 |
Why?
| Proton-Translocating ATPases | 1 | 2011 | 12 | 0.410 |
Why?
| Humans | 32 | 2022 | 54397 | 0.410 |
Why?
| Ribosomes | 1 | 2011 | 33 | 0.410 |
Why?
| RNA, Viral | 4 | 2022 | 141 | 0.410 |
Why?
| Molecular Sequence Data | 11 | 2014 | 980 | 0.400 |
Why?
| Oxidative Stress | 1 | 2016 | 958 | 0.380 |
Why?
| Oligodeoxyribonucleotides | 6 | 2003 | 30 | 0.380 |
Why?
| DNA Primase | 2 | 2020 | 8 | 0.370 |
Why?
| Binding Sites | 6 | 2017 | 440 | 0.370 |
Why?
| Movement | 1 | 2010 | 111 | 0.340 |
Why?
| DNA-Directed DNA Polymerase | 2 | 2020 | 96 | 0.340 |
Why?
| Structure-Activity Relationship | 3 | 2021 | 423 | 0.340 |
Why?
| Guanine | 4 | 2021 | 42 | 0.340 |
Why?
| Antiviral Agents | 1 | 2010 | 188 | 0.330 |
Why?
| Enzyme Activation | 4 | 2022 | 328 | 0.290 |
Why?
| Spectrometry, Fluorescence | 3 | 2010 | 53 | 0.280 |
Why?
| Protein Conformation | 5 | 2019 | 226 | 0.280 |
Why?
| Protein Multimerization | 3 | 2017 | 54 | 0.270 |
Why?
| Cross-Linking Reagents | 5 | 2014 | 42 | 0.270 |
Why?
| Dose-Response Relationship, Drug | 7 | 2018 | 1477 | 0.260 |
Why?
| Aflatoxins | 4 | 1992 | 13 | 0.250 |
Why?
| Potassium Permanganate | 2 | 2015 | 4 | 0.240 |
Why?
| Telomere-Binding Proteins | 1 | 2023 | 5 | 0.240 |
Why?
| Protein Structure, Quaternary | 2 | 2017 | 28 | 0.240 |
Why?
| Chromatography, High Pressure Liquid | 4 | 2019 | 377 | 0.220 |
Why?
| Fluorescence | 2 | 2021 | 53 | 0.220 |
Why?
| Mutation | 6 | 2020 | 1504 | 0.220 |
Why?
| Oxidation-Reduction | 5 | 2021 | 383 | 0.210 |
Why?
| Vincristine | 1 | 2022 | 98 | 0.210 |
Why?
| Phase Transition | 1 | 2021 | 6 | 0.210 |
Why?
| Genetic Techniques | 1 | 2001 | 15 | 0.200 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2021 | 35 | 0.190 |
Why?
| Hydrolysis | 2 | 2018 | 68 | 0.190 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 105 | 0.190 |
Why?
| Nucleic Acid Hybridization | 2 | 2016 | 54 | 0.190 |
Why?
| Bacteriophage T7 | 1 | 2020 | 1 | 0.190 |
Why?
| Time Factors | 5 | 2008 | 3210 | 0.180 |
Why?
| Apoptosis | 2 | 2022 | 1302 | 0.170 |
Why?
| Enzyme Stability | 2 | 2012 | 27 | 0.170 |
Why?
| Genome | 2 | 2017 | 74 | 0.170 |
Why?
| Promoter Regions, Genetic | 2 | 2021 | 520 | 0.170 |
Why?
| Biochemical Phenomena | 1 | 2018 | 3 | 0.170 |
Why?
| Transition Temperature | 1 | 2018 | 6 | 0.170 |
Why?
| Models, Biological | 3 | 2019 | 825 | 0.170 |
Why?
| Molecular Structure | 2 | 2018 | 319 | 0.170 |
Why?
| Cysteine | 1 | 1998 | 62 | 0.160 |
Why?
| Least-Squares Analysis | 2 | 2010 | 45 | 0.160 |
Why?
| Models, Genetic | 4 | 2006 | 209 | 0.160 |
Why?
| Tandem Mass Spectrometry | 1 | 2019 | 248 | 0.160 |
Why?
| Glutathione Transferase | 3 | 1993 | 178 | 0.150 |
Why?
| DNA Breaks, Double-Stranded | 2 | 2014 | 78 | 0.150 |
Why?
| RNA-Binding Proteins | 2 | 2010 | 136 | 0.150 |
Why?
| Gene Expression Regulation, Fungal | 1 | 2017 | 58 | 0.150 |
Why?
| Hot Temperature | 3 | 2005 | 199 | 0.150 |
Why?
| Fluorescence Resonance Energy Transfer | 2 | 2019 | 17 | 0.150 |
Why?
| Sequence Alignment | 3 | 2017 | 146 | 0.150 |
Why?
| Biotinylation | 4 | 2010 | 23 | 0.150 |
Why?
| Algorithms | 2 | 2014 | 697 | 0.140 |
Why?
| Protein Transport | 2 | 2019 | 195 | 0.140 |
Why?
| DNA-Directed RNA Polymerases | 1 | 2016 | 25 | 0.140 |
Why?
| Mass Spectrometry | 2 | 2014 | 313 | 0.140 |
Why?
| Multiprotein Complexes | 1 | 2016 | 30 | 0.140 |
Why?
| Microsomes, Liver | 5 | 1994 | 214 | 0.140 |
Why?
| Base Composition | 2 | 2012 | 25 | 0.140 |
Why?
| HeLa Cells | 1 | 2016 | 291 | 0.130 |
Why?
| Gene Expression Regulation | 3 | 2013 | 1063 | 0.130 |
Why?
| Bacteria | 1 | 2017 | 258 | 0.130 |
Why?
| Chromatography, Gel | 2 | 2008 | 47 | 0.130 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2010 | 79 | 0.130 |
Why?
| Sterigmatocystin | 2 | 1992 | 2 | 0.130 |
Why?
| Magnesium | 1 | 2014 | 42 | 0.130 |
Why?
| Glutathione | 3 | 1992 | 330 | 0.130 |
Why?
| 2-Aminopurine | 1 | 1994 | 1 | 0.130 |
Why?
| Genetic Loci | 1 | 2014 | 58 | 0.120 |
Why?
| Lysine | 1 | 2014 | 102 | 0.120 |
Why?
| Recombinant Fusion Proteins | 2 | 2011 | 206 | 0.110 |
Why?
| Models, Chemical | 2 | 2005 | 65 | 0.110 |
Why?
| Conserved Sequence | 1 | 2013 | 57 | 0.110 |
Why?
| DNA Footprinting | 1 | 2012 | 13 | 0.110 |
Why?
| Animals | 10 | 2012 | 14411 | 0.110 |
Why?
| RNA Viruses | 1 | 2012 | 8 | 0.110 |
Why?
| Proteome | 1 | 2014 | 178 | 0.110 |
Why?
| Amino Acid Motifs | 1 | 2012 | 57 | 0.110 |
Why?
| DNA, Circular | 1 | 2012 | 22 | 0.110 |
Why?
| Fluorescence Polarization | 2 | 2002 | 17 | 0.100 |
Why?
| Histones | 1 | 2014 | 335 | 0.100 |
Why?
| Luminescent Proteins | 1 | 2011 | 66 | 0.100 |
Why?
| Models, Statistical | 3 | 2006 | 259 | 0.090 |
Why?
| Fluorescein | 1 | 2010 | 9 | 0.090 |
Why?
| Static Electricity | 2 | 2012 | 20 | 0.090 |
Why?
| Mutagenesis | 2 | 2020 | 77 | 0.090 |
Why?
| Staining and Labeling | 1 | 2010 | 106 | 0.090 |
Why?
| Peptide Fragments | 1 | 2010 | 242 | 0.090 |
Why?
| Immunity, Innate | 1 | 2010 | 114 | 0.090 |
Why?
| Molecular Conformation | 1 | 2009 | 73 | 0.090 |
Why?
| Dimerization | 2 | 2005 | 58 | 0.090 |
Why?
| RNA, Double-Stranded | 1 | 2008 | 21 | 0.080 |
Why?
| Amino Acid Substitution | 1 | 2008 | 105 | 0.080 |
Why?
| Microscopy, Fluorescence | 2 | 2011 | 198 | 0.080 |
Why?
| Chromatography | 1 | 2008 | 16 | 0.080 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 124 | 0.080 |
Why?
| Poly U | 1 | 2008 | 5 | 0.080 |
Why?
| Mutation, Missense | 1 | 2008 | 117 | 0.080 |
Why?
| Scattering, Radiation | 1 | 2008 | 31 | 0.080 |
Why?
| Surface Plasmon Resonance | 1 | 2008 | 25 | 0.080 |
Why?
| Magnetic Resonance Spectroscopy | 4 | 1992 | 255 | 0.080 |
Why?
| Cytochrome P-450 Enzyme System | 3 | 1994 | 192 | 0.080 |
Why?
| Light | 1 | 2008 | 82 | 0.080 |
Why?
| Oncogene Proteins, Viral | 1 | 2007 | 57 | 0.080 |
Why?
| Genome, Mitochondrial | 2 | 2020 | 11 | 0.080 |
Why?
| Exodeoxyribonuclease V | 1 | 2006 | 2 | 0.070 |
Why?
| Cockayne Syndrome | 1 | 2006 | 3 | 0.070 |
Why?
| Bloom Syndrome | 1 | 2006 | 3 | 0.070 |
Why?
| DNA, Recombinant | 2 | 2010 | 17 | 0.070 |
Why?
| Antigens, Polyomavirus Transforming | 1 | 2006 | 7 | 0.070 |
Why?
| Werner Syndrome | 1 | 2006 | 14 | 0.070 |
Why?
| Eukaryotic Cells | 1 | 2006 | 20 | 0.070 |
Why?
| Ribonucleotides | 1 | 2005 | 5 | 0.070 |
Why?
| Recombination, Genetic | 1 | 2006 | 108 | 0.070 |
Why?
| Papillomaviridae | 1 | 2006 | 107 | 0.070 |
Why?
| Peptide Mapping | 1 | 2005 | 22 | 0.070 |
Why?
| Protein Denaturation | 1 | 2005 | 14 | 0.070 |
Why?
| Organophosphorus Compounds | 1 | 2005 | 17 | 0.060 |
Why?
| Cloning, Molecular | 2 | 2011 | 198 | 0.060 |
Why?
| DNA Primers | 2 | 2020 | 225 | 0.060 |
Why?
| Cell Division | 1 | 2004 | 330 | 0.060 |
Why?
| Genes, Reporter | 1 | 2003 | 98 | 0.060 |
Why?
| Plasmids | 3 | 2012 | 180 | 0.060 |
Why?
| Mitochondria | 2 | 2020 | 490 | 0.060 |
Why?
| Stereoisomerism | 2 | 1992 | 106 | 0.050 |
Why?
| Rats | 6 | 2000 | 3419 | 0.050 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2002 | 74 | 0.050 |
Why?
| Microtubules | 1 | 2022 | 57 | 0.050 |
Why?
| bcl-2-Associated X Protein | 1 | 2022 | 73 | 0.050 |
Why?
| Caspase 3 | 1 | 2022 | 135 | 0.050 |
Why?
| Mitosis | 1 | 2022 | 106 | 0.050 |
Why?
| Blotting, Western | 3 | 2010 | 684 | 0.050 |
Why?
| Thionucleotides | 1 | 2001 | 9 | 0.050 |
Why?
| Carcinogens | 2 | 1993 | 231 | 0.050 |
Why?
| Dinucleoside Phosphates | 1 | 2001 | 6 | 0.050 |
Why?
| Primaquine | 1 | 2000 | 2 | 0.050 |
Why?
| Pneumocystis Infections | 1 | 2000 | 4 | 0.050 |
Why?
| Transcription, Genetic | 2 | 2017 | 418 | 0.050 |
Why?
| Morpholines | 1 | 2001 | 64 | 0.050 |
Why?
| Cell Cycle | 1 | 2022 | 275 | 0.050 |
Why?
| Italy | 1 | 2020 | 24 | 0.050 |
Why?
| Mutagens | 2 | 1992 | 81 | 0.050 |
Why?
| Exodeoxyribonucleases | 1 | 2020 | 19 | 0.050 |
Why?
| Nucleotides | 1 | 2020 | 23 | 0.050 |
Why?
| Bacteroides fragilis | 1 | 2019 | 3 | 0.050 |
Why?
| Adenosine Diphosphate | 1 | 2019 | 23 | 0.050 |
Why?
| Catalytic Domain | 1 | 2020 | 61 | 0.050 |
Why?
| Cations | 1 | 1999 | 15 | 0.040 |
Why?
| Telomerase | 1 | 1999 | 30 | 0.040 |
Why?
| Stress, Mechanical | 1 | 2019 | 96 | 0.040 |
Why?
| Resins, Plant | 1 | 1998 | 4 | 0.040 |
Why?
| Indicators and Reagents | 1 | 1998 | 42 | 0.040 |
Why?
| Binding, Competitive | 2 | 2005 | 113 | 0.040 |
Why?
| Oxidoreductases, N-Demethylating | 2 | 1994 | 19 | 0.040 |
Why?
| DNA Topoisomerases, Type I | 1 | 2017 | 3 | 0.040 |
Why?
| Antifungal Agents | 1 | 2000 | 363 | 0.040 |
Why?
| Liver | 3 | 1993 | 1226 | 0.040 |
Why?
| Cell Line | 3 | 2005 | 1152 | 0.040 |
Why?
| Immunoprecipitation | 2 | 2007 | 73 | 0.040 |
Why?
| DNA Polymerase I | 1 | 2016 | 8 | 0.040 |
Why?
| Cytosol | 2 | 1993 | 101 | 0.030 |
Why?
| Plants, Toxic | 1 | 1994 | 12 | 0.030 |
Why?
| Succinimides | 1 | 2014 | 8 | 0.030 |
Why?
| Genome, Viral | 2 | 2005 | 100 | 0.030 |
Why?
| Mixed Function Oxygenases | 1 | 1994 | 24 | 0.030 |
Why?
| Salmonella typhimurium | 2 | 1992 | 54 | 0.030 |
Why?
| Oxidoreductases | 1 | 1994 | 62 | 0.030 |
Why?
| Hydrogen Bonding | 1 | 1994 | 45 | 0.030 |
Why?
| Mathematics | 1 | 1994 | 47 | 0.030 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 1994 | 70 | 0.030 |
Why?
| Deoxyribonuclease I | 1 | 1994 | 41 | 0.030 |
Why?
| Chromatin | 1 | 2014 | 156 | 0.030 |
Why?
| Thiones | 1 | 1993 | 2 | 0.030 |
Why?
| Phosphorylation | 2 | 2005 | 613 | 0.030 |
Why?
| Peptides | 1 | 2014 | 276 | 0.030 |
Why?
| Protein Processing, Post-Translational | 1 | 2014 | 183 | 0.030 |
Why?
| Anticarcinogenic Agents | 1 | 1993 | 35 | 0.030 |
Why?
| Thiophenes | 1 | 1993 | 37 | 0.030 |
Why?
| Sulfhydryl Compounds | 1 | 1992 | 19 | 0.030 |
Why?
| Spectrometry, Mass, Fast Atom Bombardment | 1 | 1992 | 1 | 0.030 |
Why?
| Crystallization | 1 | 1992 | 46 | 0.030 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 1992 | 33 | 0.030 |
Why?
| Cell Nucleus | 1 | 2013 | 203 | 0.030 |
Why?
| Protein Structure, Secondary | 1 | 2012 | 99 | 0.030 |
Why?
| Software | 1 | 2014 | 297 | 0.030 |
Why?
| Ethanol | 1 | 1994 | 323 | 0.030 |
Why?
| Computer Simulation | 1 | 2013 | 332 | 0.030 |
Why?
| Rats, Sprague-Dawley | 2 | 1993 | 1664 | 0.030 |
Why?
| Glutaral | 1 | 2010 | 2 | 0.020 |
Why?
| DNA, Superhelical | 1 | 1990 | 4 | 0.020 |
Why?
| Solubility | 1 | 1990 | 75 | 0.020 |
Why?
| Oligoribonucleotides | 1 | 2009 | 1 | 0.020 |
Why?
| Thymus Gland | 1 | 1990 | 45 | 0.020 |
Why?
| Phosphates | 1 | 2009 | 51 | 0.020 |
Why?
| Cattle | 1 | 1990 | 225 | 0.020 |
Why?
| Macromolecular Substances | 2 | 2002 | 47 | 0.020 |
Why?
| Mice | 3 | 1994 | 6429 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 314 | 0.020 |
Why?
| Spectrophotometry | 1 | 2005 | 36 | 0.020 |
Why?
| Collodion | 1 | 2005 | 1 | 0.020 |
Why?
| Uridine Monophosphate | 1 | 2005 | 3 | 0.020 |
Why?
| Guanosine Monophosphate | 1 | 2005 | 3 | 0.020 |
Why?
| Ultraviolet Rays | 1 | 2005 | 56 | 0.020 |
Why?
| Sequence Analysis, Protein | 1 | 2005 | 21 | 0.020 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 55 | 0.020 |
Why?
| eIF-2 Kinase | 1 | 2004 | 5 | 0.020 |
Why?
| Histidine | 1 | 2004 | 17 | 0.020 |
Why?
| Casein Kinase II | 1 | 2004 | 11 | 0.020 |
Why?
| Electroporation | 1 | 2004 | 17 | 0.020 |
Why?
| Cell Membrane | 1 | 2005 | 279 | 0.020 |
Why?
| Protein Isoforms | 1 | 2004 | 124 | 0.020 |
Why?
| Cell Line, Transformed | 1 | 2004 | 88 | 0.020 |
Why?
| Gene Deletion | 1 | 2005 | 293 | 0.020 |
Why?
| Urethane | 2 | 1994 | 8 | 0.020 |
Why?
| Pyrimidines | 1 | 2005 | 196 | 0.020 |
Why?
| Genetic Vectors | 1 | 2004 | 139 | 0.010 |
Why?
| Alkylation | 1 | 2003 | 10 | 0.010 |
Why?
| Cytochrome P-450 CYP2E1 | 2 | 1994 | 105 | 0.010 |
Why?
| RNA, Catalytic | 1 | 2002 | 3 | 0.010 |
Why?
| Esophageal Neoplasms | 1 | 2004 | 100 | 0.010 |
Why?
| Genes, Viral | 1 | 2002 | 43 | 0.010 |
Why?
| Transfection | 1 | 2003 | 399 | 0.010 |
Why?
| Pneumocystis | 1 | 2000 | 3 | 0.010 |
Why?
| Epoxy Compounds | 2 | 1992 | 48 | 0.010 |
Why?
| Drug Design | 1 | 2000 | 133 | 0.010 |
Why?
| Adenocarcinoma | 1 | 2004 | 428 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2004 | 1552 | 0.010 |
Why?
| Inhibitory Concentration 50 | 1 | 1999 | 80 | 0.010 |
Why?
| Temperature | 1 | 1999 | 177 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 1999 | 531 | 0.010 |
Why?
| Food-Drug Interactions | 1 | 1994 | 13 | 0.010 |
Why?
| Cytochrome P-450 CYP1A2 | 1 | 1994 | 46 | 0.010 |
Why?
| Cytochrome P-450 CYP3A | 1 | 1994 | 82 | 0.010 |
Why?
| Phenobarbital | 1 | 1993 | 17 | 0.010 |
Why?
| Methylenebis(chloroaniline) | 1 | 1992 | 1 | 0.010 |
Why?
| Pyrrolizidine Alkaloids | 1 | 1992 | 5 | 0.010 |
Why?
| Chromatography, Affinity | 1 | 1993 | 50 | 0.010 |
Why?
| Enzyme Induction | 1 | 1993 | 80 | 0.010 |
Why?
| Biological Assay | 1 | 1992 | 55 | 0.010 |
Why?
| Biotransformation | 1 | 1992 | 100 | 0.010 |
Why?
| Male | 1 | 1992 | 27348 | 0.010 |
Why?
| Mutagenicity Tests | 1 | 1989 | 56 | 0.010 |
Why?
| Furans | 1 | 1989 | 27 | 0.010 |
Why?
| Female | 1 | 2000 | 28474 | 0.000 |
Why?
|
|
Raney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|